TCF12
Transcription factor 12
Also known as: bHLHb20, HEB, HsT17266, HTF4, HTF4_HUMAN, p64
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q99081
- Gene
- TCF12
- Ensembl
- ENSG00000140262
- Chromosome
- 15
- Canonical length
- 682 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nuclear speckles
OverviewNCBI Gene
The protein encoded by this gene is a member of the basic helix-loop-helix (bHLH) E-protein family that recognizes the consensus binding site (E-box) CANNTG. This encoded protein is expressed in many tissues, among them skeletal muscle, thymus, B- and T-cells, and may participate in regulating lineage-specific gene expression through the formation of heterodimers with other bHLH E-proteins. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
682 residues, UniProt reviewed canonical sequence.
>Q99081|TCF12
1 MNPQQQRMAA IGTDKELSDL LDFSAMFSPP VNSGKTRPTT LGSSQFSGSG IDERGGTTSW
61 GTSGQPSPSY DSSRGFTDSP HYSDHLNDSR LGAHEGLSPT PFMNSNLMGK TSERGSFSLY
121 SRDTGLPGCQ SSLLRQDLGL GSPAQLSSSG KPGTAYYSFS ATSSRRRPLH DSAALDPLQA
181 KKVRKVPPGL PSSVYAPSPN SDDFNRESPS YPSPKPPTSM FASTFFMQDG THNSSDLWSS
241 SNGMSQPGFG GILGTSTSHM SQSSSYGNLH SHDRLSYPPH SVSPTDINTS LPPMSSFHRG
301 STSSSPYVAA SHTPPINGSD SILGTRGNAA GSSQTGDALG KALASIYSPD HTSSSFPSNP
361 STPVGSPSPL TGTSQWPRPG GQAPSSPSYE NSLHSLQSRM EDRLDRLDDA IHVLRNHAVG
421 PSTSLPAGHS DIHSLLGPSH NAPIGSLNSN YGGSSLVASS RSASMVGTHR EDSVSLNGNH
481 SVLSSTVTTS STDLNHKTQE NYRGGLQSQS GTVVTTEIKT ENKEKDENLH EPPSSDDMKS
541 DDESSQKDIK VSSRGRTSST NEDEDLNPEQ KIEREKERRM ANNARERLRV RDINEAFKEL
601 GRMCQLHLKS EKPQTKLLIL HQAVAVILSL EQQVRERNLN PKAACLKRRE EEKVSAVSAE
661 PPTTLPGTHP GLSETTNPMG HMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TCF12 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 124 nTPM
Expression across tissuesHPA
Tissue
- thymus: 124 nTPM
- cervix: 71 nTPM
- cerebral cortex: 61 nTPM
- endometrium: 45 nTPM
- fallopian tube: 44 nTPM
- parathyroid gland: 41 nTPM
Single-cell type
- oligodendrocytes: 2,035 nCPM
- microglia: 1,128 nCPM
- oligodendrocyte progenitor cells: 1,036 nCPM
- bergmann glia: 895 nCPM
- endometrial stromal cells: 888 nCPM
- pituicytes/fscs: 777 nCPM
Immune cell
- basophil: 28 nTPM
- non-classical monocyte: 27 nTPM
- T-reg: 23 nTPM
- myeloid DC: 20 nTPM
- intermediate monocyte: 18 nTPM
- gdT-cell: 17 nTPM
Brain region
- white matter: 117 nTPM
- basal ganglia: 97 nTPM
- medulla oblongata: 95 nTPM
- midbrain: 86 nTPM
- cerebellum: 82 nTPM
- pons: 81 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TCF12.
Disease | AllUniProt
Conditions TCF12 is implicated in, by any mechanism.
- Craniosynostosis 3 (CRS3) MIM:615314
- Hypogonadotropic hypogonadism 26 with or without anosmia (HH26) MIM:619718
Disease | GeneticClinVar
138 pathogenic / likely-pathogenic of 560 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- TCF12-related craniosynostosis
- Hypogonadotropic hypogonadism 26 with or without anosmia
- TCF12-related disorder
- HYPOGONADOTROPIC HYPOGONADISM 26 WITH ANOSMIA
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.37
- gnomAD pLI
- 0.68
- gnomAD missense Z
- 0.89
- DepMap mean gene effect
- -0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- gene expression
- immune response
- muscle organ development
- nervous system development
- positive regulation of gene expression
- positive regulation of neuron differentiation
- positive regulation of transcription by RNA polymerase II
- regulation of transcription by RNA polymerase II
- response to gonadotropin-releasing hormone
Molecular functions
- bHLH transcription factor binding
- cAMP response element binding
- cis-regulatory region sequence-specific DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription factor binding
- E-box binding
- HMG box domain binding
- protein heterodimerization activity
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- sequence-specific double-stranded DNA binding
- SMAD binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TCF12 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TCF12 as an antibody target. Whether an autoantibody or antibody against TCF12 could matter depends on whether native TCF12 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TCF12 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label TCF12 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...